1. Home
  2. IMXI vs FBRX Comparison

IMXI vs FBRX Comparison

Compare IMXI & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.24

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$16.87

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
FBRX
Founded
1994
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
487.2M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
IMXI
FBRX
Price
$15.24
$16.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$15.00
$67.00
AVG Volume (30 Days)
827.6K
205.1K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.30
EPS
0.02
N/A
Revenue
$319,601,000.00
$36,000.00
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
$757.00
N/A
Revenue Growth
16.68
N/A
52 Week Low
$8.58
$9.12
52 Week High
$15.95
$35.80

Technical Indicators

Market Signals
Indicator
IMXI
FBRX
Relative Strength Index (RSI) 40.52 28.04
Support Level $14.87 $10.50
Resistance Level $15.53 $17.00
Average True Range (ATR) 0.21 1.97
MACD -0.00 -0.34
Stochastic Oscillator 55.97 1.82

Price Performance

Historical Comparison
IMXI
FBRX

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: